Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Annals of Clinical and Translational Neurology
|
June 29, 2025
Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP Antibodies
Michael Levraut, Romain Marignier, Mikael Cohen, et al.
Viruses
|
March 26, 2022
Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients
Marion Cremoni, Sébastien Cuozzo, Emanuela Martinuzzi, et al.
Ebiomedicine
|
October 2, 2022
Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
Jonathan Allouche, Marion Cremoni, Vesna Brglez, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2021
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
Alexandre Gérard, Jerome Doyen, Marion Cremoni, et al.
Clinical Kidney Journal
|
September 26, 2022
Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study
Alexandre O Gérard, Susana Barbosa, Nadège Parassol, et al.
Frontiers in Immunology
|
October 13, 2022
Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
Marion Cremoni, Jonathan Allouche, Daisy Graça, et al.
Kidney International Reports
|
February 5, 2024
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence
Alexandre Destere, Maxime Teisseyre, Diane Merino, et al.
Clinical Kidney Journal
|
May 5, 2025
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy
Maxime Teisseyre, Alexandre Destere, Marion Cremoni, et al.
Kidney International Reports
|
August 15, 2025
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
Marco Allinovi, Maxime Teisseyre, Matteo Accinno, et al.
Ebiomedicine
|
November 11, 2021
Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients
Filippo Massa, Marion Cremoni, Alexandre Gérard, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Annals of Clinical and Translational Neurology
|
June 29, 2025
Relevance of Kappa and Lambda Free Light Chains in Autoimmune Astrocytopathy Associated With Anti-GFAP Antibodies
Michael Levraut, Romain Marignier, Mikael Cohen, et al.
Viruses
|
March 26, 2022
Low T Cell Responsiveness in the Early Phase of COVID-19 Associates with Progression to Severe Pneumonia in Kidney Transplant Recipients
Marion Cremoni, Sébastien Cuozzo, Emanuela Martinuzzi, et al.
Ebiomedicine
|
October 2, 2022
Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
Jonathan Allouche, Marion Cremoni, Vesna Brglez, et al.
Journal for Immunotherapy of Cancer
|
June 5, 2021
Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
Alexandre Gérard, Jerome Doyen, Marion Cremoni, et al.
Clinical Kidney Journal
|
September 26, 2022
Risk factors associated with immune checkpoint inhibitor-induced acute kidney injury compared with other immune-related adverse events: a case-control study
Alexandre O Gérard, Susana Barbosa, Nadège Parassol, et al.
Frontiers in Immunology
|
October 13, 2022
Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
Marion Cremoni, Jonathan Allouche, Daisy Graça, et al.
Kidney International Reports
|
February 5, 2024
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence
Alexandre Destere, Maxime Teisseyre, Diane Merino, et al.
Clinical Kidney Journal
|
May 5, 2025
Artificial intelligence to guide rituximab therapy in patients with phospholipase A2 receptor-associated membranous nephropathy
Maxime Teisseyre, Alexandre Destere, Marion Cremoni, et al.
Kidney International Reports
|
August 15, 2025
Anti-Rituximab Antibodies Occurrence and Clinical Outcomes in Patients With Primary Membranous Nephropathy
Marco Allinovi, Maxime Teisseyre, Matteo Accinno, et al.
Ebiomedicine
|
November 11, 2021
Safety and cross-variant immunogenicity of a three-dose COVID-19 mRNA vaccine regimen in kidney transplant recipients
Filippo Massa, Marion Cremoni, Alexandre Gérard, et al.
Page
of 4